Chemotherapieinduzierte Nausea und Emesis: Aktuelle Empfehlungen zur Prophylaxe

Translated title of the contribution: Chemotherapy-induced nausea and vomiting: Current recommendations for prophylaxis

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations

Abstract

The chemotherapy-induced nausea and vomiting (CINV) is one of the most frequent side effects in cytostatic therapy and a profound challenge during the therapy of cancer patients. Therefore, standardized guideline-orientated prophylaxis is essential and a fundamental contribution for the success of treatment. This review summarizes the current recommendations for CINV of the Multinational Association of Supportive Care in Cancer (MASCC) and European Society of Medical Oncology (ESMO), the American Society for Clinical Oncology (ASCO), the National Comprehensive Cancer Network (NCCN) and the S3-guideline Supportive Therapie of the Leitlinienprogramm Onkologie and shall facilitate its use in the daily routine.

Translated title of the contributionChemotherapy-induced nausea and vomiting: Current recommendations for prophylaxis
Original languageGerman
Pages (from-to)532-542
Number of pages11
JournalUrologe - Ausgabe A
Volume57
Issue number5
DOIs
StatePublished - 1 May 2018

Fingerprint

Dive into the research topics of 'Chemotherapy-induced nausea and vomiting: Current recommendations for prophylaxis'. Together they form a unique fingerprint.

Cite this